Lifeward Ltd. Ordinary Shares (LFWD) Stock Price

LFWDStock

$6.00−34.28%52W

Market Cap$16.99M

P/E—

PEG Ratio—

Div yield—

Beta0.57

LFWD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-17.60%

Price vs S&P 500 (4W)-12.96%

VGM Score58.20

Book Value / Share (Quarterly)$4.32

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)58.72%

Cash Flow / Share (Quarterly)$-6.04

Price vs S&P 500 (YTD)-25.02%

Gross Margin (TTM)32.89%

Net Profit Margin (TTM)-177.00%

EPS (TTM)$-16.78

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-16.78

Revenue Growth (5Y)38.06%

EPS (Annual)$-17.16

ROI (Annual)-177.63%

Gross Margin (Annual)38.25%

Net Profit Margin (5Y Avg)-186.30%

Cash / Share (Quarterly)$3.34

Revenue Growth QoQ (YoY)15.71%

ROA (Last FY)-86.96%

Revenue Growth TTM (YoY)-36.04%

EBITD / Share (TTM)$-12.42

ROE (5Y Avg)-96.19%

Operating Margin (TTM)-125.48%

Cash Flow / Share (Annual)$-11.05

P/B Ratio1.39x

P/B Ratio (Quarterly)1.76x

Net Income / Employee (Annual)$-245,900

EV / Revenue (TTM)0.77x

Net Interest Coverage (TTM)-116.46x

ROA (TTM)-107.72%

EPS Incl Extra (Annual)$-17.16

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.60x

3-Month Avg Trading Volume0.01M

52-Week Price Return-34.28%

Revenue / Employee (TTM)$192,900

Tangible BV / Share (Quarterly)$4.17

P/S Ratio (Annual)0.77x

Asset Turnover (Annual)0.96x

52-Week High$9.61

Operating Margin (5Y Avg)-186.56%

EPS Excl Extra (Annual)$-17.16

CapEx CAGR (5Y)-26.18%

26-Week Price Return-7.69%

Quick Ratio (Annual)0.74x

13-Week Price Return-23.47%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)2.33x

Enterprise Value$11.98M

Revenue / Share Growth (5Y)57.63%

Asset Turnover (TTM)0.51x

Revenue / Employee (Annual)$272,000

Inventory Turnover (Annual)2.18x

Pretax Margin (Annual)-90.63%

Cash / Share (Annual)$1.42

3-Month Return Std Dev49.66%

Gross Margin (5Y Avg)37.13%

Net Income / Employee (TTM)$-380,600

ROE (Last FY)-236.85%

Net Interest Coverage (Annual)-2.45x

EPS Basic Excl Extra (Annual)$-17.16

Receivables Turnover (TTM)2.28x

Total Debt / Equity (Quarterly)0.36x

EPS Incl Extra (TTM)$-16.78

Receivables Turnover (Annual)3.63x

ROI (TTM)-227.61%

P/S Ratio (TTM)1.09x

Pretax Margin (5Y Avg)-184.32%

Revenue / Share (Annual)$18.99

Tangible BV / Share (Annual)$25.68

Price vs S&P 500 (52W)-49.81%

Year-to-Date Return-13.29%

5-Day Price Return-3.54%

EPS Normalized (Annual)$-17.16

ROA (5Y Avg)-51.34%

Net Profit Margin (Annual)-90.38%

Month-to-Date Return-9.10%

EBITD / Share (Annual)$-16.67

Operating Margin (Annual)-89.29%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-84.35%

LT Debt / Equity (Quarterly)0.36x

EPS Basic Excl Extra (TTM)$-16.78

P/TBV (Quarterly)1.83x

P/B Ratio (Annual)1.25x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-177.37%

Book Value / Share (Annual)$5.52

Price vs S&P 500 (13W)-26.15%

Beta0.57x

Revenue / Share (TTM)$5.59

ROE (TTM)-310.86%

52-Week Low$4.14

vGradeA

gGradeC

mGradeC

vgmGradeC

LFWD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$1.28	-$1.46	-14.06%(-$0.18)
Q1 2026	May 15, 2026	-$0.34	-$6.70	-1870.59%(-$6.36)
Q4 2025	Mar 18, 2026	-$1.08	-$2.85	-163.89%(-$1.77)
Q3 2025	Nov 14, 2025	-$1.92	-$2.28	-18.75%(-$0.36)
Q2 2025	Aug 14, 2025	-$2.88	-$3.72	-29.17%(-$0.84)

LFWD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Lifeward Ltd. Ordinary Shares

Lifeward Ltd develops and commercializes medical devices for rehabilitation and recovery, including wearable exoskeletons, powered suits, functional electrical stimulation bikes, and anti-gravity systems. The company serves multiple care settings—clinical, home, and community—with operations in the United States, Israel, and Germany.

LFWD Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$1.04

Revenue estimate$7.24M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

PAVMPAVmed Inc. Common StockSurgical & Medical Instruments
ARAYAccuray IncorporatedSurgical & Medical Instruments
BDMDBaird Medical Investment Holdings Ltd Ordinary ShareSurgical & Medical Instruments
RVPRetractable Technologies, IncSurgical & Medical Instruments
ICUSeaStar Medical Holding Corporation Common StockSurgical & Medical Instruments
CLIRClearSign Technologies Corporation Common Stock (DE)Industrial Instruments
BNGOBionano Genomics, Inc. Common StockLab Analytical Instruments
IRIXIridex CorpElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$4.14

High$9.61